Product
Coagulation factor VIIa [recombinant]-jncw
1 clinical trial
2 indications
Indication
Hemophilia A with inhibitorIndication
Hemophilia B with InhibitorClinical trial
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With InhibitorsStatus: Recruiting, Estimated PCD: 2024-11-30